Analysts’ Price Target Changes for August 5th (BXP, CDP, CPT, DNLI, EGP, EQR, ESS, HR, LLY, MAA)

Analysts’ price target changes for Monday, August 5th:

Boston Properties (NYSE:BXP) had its price target raised by Wedbush from $63.00 to $70.00. They currently have a neutral rating on the stock.

COPT Defense Properties (NYSE:CDP) had its target price increased by Wedbush from $28.00 to $33.00. Wedbush currently has an outperform rating on the stock.

Camden Property Trust (NYSE:CPT) had its target price raised by Wedbush from $118.00 to $131.00. Wedbush currently has an outperform rating on the stock.

Denali Therapeutics (NASDAQ:DNLI) had its price target trimmed by HC Wainwright from $95.00 to $90.00. HC Wainwright currently has a buy rating on the stock.

EastGroup Properties (NYSE:EGP) had its price target increased by Wedbush from $208.00 to $209.00. Wedbush currently has an outperform rating on the stock.

Equity Residential (NYSE:EQR) had its target price increased by Wedbush from $68.00 to $75.00. Wedbush currently has a neutral rating on the stock.

Essex Property Trust (NYSE:ESS) had its price target increased by Wedbush from $264.00 to $301.00. The firm currently has a neutral rating on the stock.

Healthcare Realty Trust (NYSE:HR) had its price target raised by Wedbush from $15.00 to $18.00. The firm currently has a neutral rating on the stock.

Eli Lilly and Company (NYSE:LLY) had its price target boosted by Guggenheim from $855.00 to $884.00. The firm currently has a buy rating on the stock.

Mid-America Apartment Communities (NYSE:MAA) had its price target increased by Wedbush from $154.00 to $184.00. Wedbush currently has an outperform rating on the stock.

Microchip Technology (NASDAQ:MCHP) had its target price cut by Needham & Company LLC from $100.00 to $96.00. They currently have a buy rating on the stock.

Monolithic Power Systems (NASDAQ:MPWR) had its target price increased by Needham & Company LLC from $800.00 to $1,000.00. They currently have a buy rating on the stock.

Neurocrine Biosciences (NASDAQ:NBIX) had its price target raised by HC Wainwright from $160.00 to $190.00. The firm currently has a buy rating on the stock.

NRx Pharmaceuticals (NASDAQ:NRXP) had its target price increased by HC Wainwright from $2.00 to $19.00. The firm currently has a buy rating on the stock.

Plymouth Industrial REIT (NYSE:PLYM) had its target price increased by Wedbush from $23.00 to $25.00. The firm currently has a neutral rating on the stock.

Block (NYSE:SQ) had its price target trimmed by Needham & Company LLC from $105.00 to $80.00. The firm currently has a buy rating on the stock.

STAG Industrial (NYSE:STAG) had its target price increased by Wedbush from $44.00 to $45.00. Wedbush currently has an outperform rating on the stock.

Travere Therapeutics (NASDAQ:TVTX) had its price target raised by HC Wainwright from $19.00 to $20.00. They currently have a buy rating on the stock.

UDR (NYSE:UDR) had its price target increased by Wedbush from $45.00 to $49.00. The firm currently has an outperform rating on the stock.

Vertex Pharmaceuticals (NASDAQ:VRTX) had its price target increased by HC Wainwright from $500.00 to $600.00. They currently have a buy rating on the stock.

Ventas (NYSE:VTR) had its target price boosted by Wedbush from $54.00 to $64.00. Wedbush currently has an outperform rating on the stock.

Welltower (NYSE:WELL) had its target price boosted by Wedbush from $100.00 to $120.00. They currently have a neutral rating on the stock.